PCMH
NRIX icon

Polymer Capital Management (HK)’s Nurix Therapeutics NRIX Stock Holding History

Polymer Capital Management (HK)’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Hold
58,898
– – 0.07% 102
2026
Q1 		$913K Hold
58,898
– – 0.08% 112
2025
Q4 		$1.12M Hold
58,898
– – 0.16% 79
2025
Q3 		$544K Hold
58,898
– – 0.08% 129
2025
Q2 		$671K Hold
58,898
– – 0.1% 106
2025
Q1 		$700K Buy
58,898
+8,800
+18% +$147K 0.12% 102
2024
Q4 		$944K Buy
+50,098
New +$1.15M 0.16% 116

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Polymer Capital Management (HK)'s NRIX Position: Q2 2026 in Review

Polymer Capital Management (HK) held its Nurix Therapeutics (NRIX) position steady in Q2 2026 at 58,898 shares worth $1.43M. The position accounts for 0.07% of the portfolio, ranked #102.

Polymer Capital Management (HK) first reported a position in NRIX in Q4 2024 and has held it in 7 quarters since. 212 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Polymer Capital Management (HK) held 58,898 shares of Nurix Therapeutics worth $1.43M as of Q2 2026.
  • Polymer Capital Management (HK) left its Nurix Therapeutics share count unchanged in Q2 2026.
  • Nurix Therapeutics made up 0.07% of Polymer Capital Management (HK)'s portfolio in Q2 2026, its #102 holding.
  • Polymer Capital Management (HK) first reported a position in Nurix Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 212 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Polymer Capital Management (HK)'s 13F filing for Q2 2026, filed 13 Aug 2026.